1. Home
  2. LQDA vs CVBF Comparison

LQDA vs CVBF Comparison

Compare LQDA & CVBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LQDA

Liquidia Corporation

HOLD

Current Price

$63.23

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Logo CVB Financial Corporation

CVBF

CVB Financial Corporation

HOLD

Current Price

$20.46

Market Cap

3.5B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
LQDA
CVBF
Founded
2004
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.5B
IPO Year
2020
2009

Fundamental Metrics

Financial Performance
Metric
LQDA
CVBF
Price
$63.23
$20.46
Analyst Decision
Strong Buy
Buy
Analyst Count
11
3
Target Price
$41.00
$24.50
AVG Volume (30 Days)
1.7M
1.3M
Earning Date
05-08-2026
04-22-2026
Dividend Yield
N/A
3.95%
EPS Growth
51.81
5.56
EPS
0.52
0.38
Revenue
$158,320,000.00
N/A
Revenue This Year
$278.87
$21.47
Revenue Next Year
$57.13
$15.21
P/E Ratio
$107.10
$52.32
Revenue Growth
1031.18
N/A
52 Week Low
$11.85
$17.95
52 Week High
$63.46
$21.48

Technical Indicators

Market Signals
Indicator
LQDA
CVBF
Relative Strength Index (RSI) 67.44 53.73
Support Level $30.48 $19.84
Resistance Level $63.46 $20.85
Average True Range (ATR) 3.55 0.40
MACD -0.68 -0.00
Stochastic Oscillator 74.24 69.39

Price Performance

Historical Comparison
LQDA
CVBF

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

About CVBF CVB Financial Corporation

CVB Financial Corp is the holding company for Citizens Business Bank. Citizens Business Bank offers banking, lending, and investing services. It provides a full complement of lending products, including commercial, agribusiness, consumer, SBA, real estate, and construction loans, as well as equipment and vehicle leasing. Commercial products include lines of credit and other working capital financing, accounts receivable lending and letters of credit. It is a community bank with one reportable operating segment.

Share on Social Networks: